PHIO Q3 2018 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena

PHIOPhio Pharmaceuticals Corp.

$13M

Q3 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$57,000

Gross Profit

-$781,000-1370.2% margin

Operating Income

-$1M-2617.5% margin

Net Income

-$1M-2619.3% margin

EPS (Diluted)

$-2030.87

QoQ Revenue Growth

-1.7%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$39,000

Balance Sheet

Total Assets

$4M

Total Liabilities

$2M

Stockholders' Equity

$2M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$57,000	$0	—
Gross Profit	-$781,000	-$1M	+47.6%
Operating Income	-$1M	-$2M	+39.7%
Net Income	-$1M	-$2M	+39.7%